News headlines about Global Medical REIT (NASDAQ:GMRE) have trended somewhat positive on Friday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Global Medical REIT earned a news impact score of 0.14 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.6792496764991 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the headlines that may have effected Accern’s scoring:

A number of equities analysts have recently issued reports on the company. TheStreet raised Global Medical REIT from a “d” rating to a “c-” rating in a research note on Monday, July 10th. Zacks Investment Research raised Global Medical REIT from a “hold” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Wednesday, July 12th. Finally, FBR & Co reissued an “outperform” rating and set a $10.00 target price on shares of Global Medical REIT in a research note on Tuesday, July 11th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $10.67.

Global Medical REIT (GMRE) traded up 2.39% during trading on Friday, reaching $8.99. The company had a trading volume of 70,788 shares. Global Medical REIT has a 52-week low of $6.73 and a 52-week high of $11.24. The company has a 50-day moving average of $9.16 and a 200-day moving average of $9.04.

Global Medical REIT (NASDAQ:GMRE) last issued its quarterly earnings data on Thursday, August 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.13 by $0.17. Global Medical REIT had a negative return on equity of 6.70% and a negative net margin of 54.55%. The business had revenue of $7.42 million for the quarter, compared to analyst estimates of $6.16 million. On average, equities research analysts forecast that Global Medical REIT will post ($0.09) EPS for the current year.

In other news, Chairman Jeffrey Busch bought 11,100 shares of the company’s stock in a transaction that occurred on Friday, June 30th. The shares were purchased at an average price of $9.00 per share, with a total value of $99,900.00. Following the completion of the acquisition, the chairman now directly owns 20,110 shares in the company, valued at $180,990. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

TRADEMARK VIOLATION NOTICE: This article was first posted by Daily Political and is the property of of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.dailypolitical.com/2017/08/11/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-global-medical-reit-nasdaqgmre-share-price.html.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.